Document Detail


Prevention of serious respiratory syncytial virus-related illness. II: Immunoprophylaxis.
MedLine Citation:
PMID:  21318605     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Respiratory syncytial virus (RSV) causes significant morbidity in very young children, preterm infants with and without chronic lung disease, and children with hemodynamically significant congenital heart disease. In the absence of a safe and effective vaccine, alternative means of protecting high-risk infants and young children from serious RSV illness have been studied. Clinical observations and animal model data over the past 30 years suggested that RSV immunoglobulin G (IgG) neutralizing antibodies might offer protection from severe RSV lower respiratory tract disease. Transfer of adequate amounts of IgG to the fetus does not occur efficiently until the third trimester of pregnancy, which helps to explain why premature infants are at high risk of serious RSV illness. Efforts shifted toward the prophylactic monthly administration of standard immunoglobulins and, later, of RSV-enriched immunoglobulin in selected high-risk infants and young children. Although this approach proved effective, RSV-enriched immune globulin was not suitable for all patients and administration was labor intensive. The development of palivizumab, a monoclonal antibody that can bind to a specific antigenic site on the virus and prevent cell-to-cell spread of infection has since become the mainstay of RSV illness prevention in preterm infants and those with significant congenital heart disease. Palivizumab, the only monoclonal antibody approved for the prevention of RSV lower respiratory tract disease must be administered monthly throughout the RSV season and does not always prevent serious RSV illness. Further research to develop more effective and less labor-intensive immunoprophylactic agents is ongoing.
Authors:
Jessie R Groothuis; J Michael Hoopes; Val G Hemming
Related Documents :
14710115 - Cord c-peptide and insulin-like growth factor-i, birth weight, and placenta weight amon...
17098575 - Mothers tended to overreport categorical infant birth weight of their children.
9132405 - Evaluation of a clinic for pregnant adolescents.
2786085 - Relationship between maternal and infant nutritional status.
9575645 - A study on some immunological parameters in infants with salmonellosis.
8034765 - Neuropsychologic function in same-sex twins discordant for perinatal brain damage.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-2-4
Journal Detail:
Title:  Advances in therapy     Volume:  -     ISSN:  1865-8652     ISO Abbreviation:  -     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-2-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8611864     Medline TA:  Adv Ther     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
MedImmune, LLC, 1 MedImmune Way, Gaithersburg, MD, 20878, USA, GroothuisJ@MedImmune.com.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Efficacy and safety of mometasone furoate nasal spray in the treatment of chronic rhinosinusitis.
Next Document:  Prevention of serious respiratory syncytial virus-related illness. I: Disease pathogenesis and early...